First Manhattan’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

First Manhattan’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$524K	Hold	4,100	–	–	﹤0.01%	558
2025 Q4	$500K	Sell	4,100 -340	-8%	-$39K	﹤0.01%	559
2025 Q3	$445K	Buy	4,440 +640	+17%	+$57.6K	﹤0.01%	564
2025 Q2	$315K	Sell	3,800 -10	-0.3%	-$798	﹤0.01%	609
2025 Q1	$309K	Hold	3,810	–	–	﹤0.01%	581
2024 Q4	$343K	Buy	3,810 +10	+0.3%	+$969	﹤0.01%	578
2024 Q3	$375K	Hold	3,800	–	–	﹤0.01%	544
2024 Q2	$352K	Hold	3,800	–	–	﹤0.01%	542
2024 Q1	$361K	Buy	3,800 +300	+9%	+$27.8K	﹤0.01%	558
2023 Q4	$313K	Hold	3,500	–	–	﹤0.01%	566
2023 Q3	$256K	Sell	3,500 -600	-15%	-$47.9K	﹤0.01%	617
2023 Q2	$341K	Hold	4,100	–	–	﹤0.01%	562
2023 Q1	$312K	Sell	4,100 -3,100	-43%	-$257K	﹤0.01%	594
2022 Q4	$598K	Hold	7,200	–	–	﹤0.01%	488
2022 Q3	$571K	Hold	7,200	–	–	﹤0.01%	490
2022 Q2	$534K	Buy	7,200 +7,000	+3,500%	+$525K	﹤0.01%	526
2022 Q1	$17K	Hold	200	–	–	﹤0.01%	1198
2021 Q4	$22K	Hold	200	–	–	﹤0.01%	1152
2021 Q3	$25K	Hold	200	–	–	﹤0.01%	1132
2021 Q2	$27K	Buy	+200	New	+$26.3K	﹤0.01%	1113
2021 Q1	–	Sell	-100	Closed	-$14K	–	1571
2020 Q4	$14K	Hold	100	–	–	﹤0.01%	1110
2020 Q3	$11K	Buy	+100	New	+$11.2K	﹤0.01%	1123
2018 Q2	–	Sell	-74	Closed	-$6K	–	1428
2018 Q1	$6K	Hold	74	–	–	﹤0.01%	1249
2017 Q4	$6K	Hold	74	–	–	﹤0.01%	1297
2017 Q3	$6K	Buy	+74	New	+$5.93K	﹤0.01%	1277
2015 Q4	–	Sell	-852	Closed	-$53K	–	1489
2015 Q3	$53K	Hold	852	–	–	﹤0.01%	925
2015 Q2	$71K	Hold	852	–	–	﹤0.01%	894
2015 Q1	$64K	Buy	+852	New	+$59.5K	﹤0.01%	923

Other funds holding XBI

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

First Manhattan's XBI Position: Q1 2026 in Review

First Manhattan held its State Street SPDR S&P Biotech ETF (XBI) position steady in Q1 2026 at 4,100 shares worth $524K. The position accounts for ﹤0.01% of the portfolio, ranked #558.

First Manhattan first reported a position in XBI in Q1 2015 and has held it in 28 quarters since. The position peaked at $598K in Q4 2022. 813 funds tracked by Wall St. Rank hold XBI as of Q1 2026.

First Manhattan held 4,100 shares of State Street SPDR S&P Biotech ETF worth $524K as of Q1 2026.
First Manhattan left its State Street SPDR S&P Biotech ETF share count unchanged in Q1 2026.
State Street SPDR S&P Biotech ETF made up ﹤0.01% of First Manhattan's portfolio in Q1 2026, its #558 holding.
First Manhattan first reported a position in State Street SPDR S&P Biotech ETF in Q1 2015 and has held it in 28 quarters since.
First Manhattan's State Street SPDR S&P Biotech ETF position peaked at $598K in Q4 2022.
813 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2026.

Based on First Manhattan's 13F filing for Q1 2026, filed 15 May 2026.